Brief: Catheter Precision To Acquire Assets In Development For Late-Stage Treatment For Acute Decompensated Heart Failure
23/04/2025 13:20
April 23 (Reuters) - Catheter Precision Inc VTAK.A: CATHETER PRECISION TO ACQUIRE ASSETS IN DEVELOPMENT FOR LATE-STAGE TREATMENT FOR ACUTE DECOMPENSATED HEART FAILURE Source text: ID:nGNX885c94 Further company coverage: VTAK.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Flyte Aviation
See all newsBrief: Catheter Precision Announces Publication Of Comparative Study Showing Locket Outperforms Abbott’S Perclose Internal Vascular Closure Device
Brief: Flyte Aviation - Announces Multi-Year Partnership With Philadelphia 76Ers - SEC Filing
Brief: Catheter Precision To Change Its Name And Ticker Symbol To Flyte Aviation And "Vjet"
Brief: Catheter Precision Board Approves Name Change To Flyte Aviation
Brief: Flyte Secures International Approval To Launch Private Aviation Service Across The Bahamas And Caribbean